All Stories

  1. Emerged SARS-CoV-2 intermediate hosts: The missing links from One Health perspective
  2. Curcumin-piperine nanoparticles mitigate cuprizone-induced cognitive impairment via antioxidant and anti-inflammatory mechanisms
  3. MicroRNAs: From Bench to Bedside Applications as Breast Cancer Therapeutics
  4. Network Pharmacology-Guided Identification of Therapeutic Targets and Pathways for Cancer Stem Cell Inhibition Across Multiple Cancer Types
  5. Role of Circular RNAs in Regulating Tumor Microenvironment, Epithelial Mesenchymal Transition, and Resistance to Cancer Therapy
  6. Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions
  7. Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment
  8. A Novel Synergized Nanoformulation Revives the Activity of Ineffective Ceftibuten Antibiotic: Synthesis, Characterization, In Vitro Validation and Molecular Interactions Study
  9. Leveraging AI and Natural Compounds: Innovative Approaches in the Diagnosis and Treatment of Hepatocellular Carcinoma
  10. Computational Exploration of a Diverse Flavonoid Library for Targeted Allosteric Inhibition of AKT1 in Cancer Therapy
  11. Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer’s Disease
  12. Anticancer potential of Cu4O3 NPs against human ovarian teratocarcinoma: an in-vitro validation
  13. Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa: Advancements in computational therapeutics
  14. Analysis of some flavonoids for inhibitory mechanism against cancer target phosphatidylinositol 3-kinase (PI3K) using computational tool
  15. Interlinking of diabetes mellitus and cancer: An overview
  16. Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy
  17. Husk-like Zinc Oxide Nanoparticles Induce Apoptosis through ROS Generation in Epidermoid Carcinoma Cells: Effect of Incubation Period on Sol-Gel Synthesis and Anti-Cancerous Properties
  18. Targeting a transcription factor NF-κB by green tea catechins using in silico and in vitro studies in pancreatic cancer
  19. Association of interleukin-18 promoter polymorphism with comorbid conditions of cardiovascular disease
  20. Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27, 5042
  21. Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies
  22. Advancement of cancer immunotherapy using nanoparticles-based nanomedicine
  23. Investigating the anticancer efficacy of biogenic synthesized MgONPs: An in vitro analysis
  24. Where do T cell subsets stand in SARS-CoV-2 infection: an update
  25. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression
  26. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview
  27. The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer
  28. Identification of anticancer bioactive compounds derived from Ficus sp. by targeting Poly[ADP-ribose]polymerase 1 (PARP-1)
  29. Association of IL-6 promoter polymorphism hotspots (− 174G/C and − 572G/C) with cardiovascular disease risk factors
  30. Biosynthesis of ZnO NPs from pumpkin seeds’ extract and elucidation of its anticancer potential against breast cancer
  31. Evaluation of Anticancer Potential of Biogenic Copper Oxide Nanoparticles (CuO NPs) against Breast Cancer
  32. Biosynthesis of copper oxide nanoparticles and its therapeutic efficacy against colon cancer
  33. Flavonoids and PI3K/Akt/mTOR Signaling Cascade: A Potential Crosstalk in Anticancer Treatment
  34. Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
  35. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options
  36. Polyphenols as anticancer agents: Toxicological concern to healthy cells
  37. Dissecting Sex‐Related Cognition between Alzheimer’s Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies
  38. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2
  39. Analysis of sugar composition and pesticides using HPLC and GC–MS techniques in honey samples collected from Saudi Arabian markets
  40. A critical transcription factor NF-κB as a cancer therapeutic target and its inhibitors as cancer treatment options
  41. Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy
  42. Calcium-/Calmodulin-Dependent Protein Kinase IV (CAMKIV): A Multifunctional Enzyme and Its Role in Various Cancer: An Update
  43. Exploring Inhibitory Mechanisms of Green Tea Catechins as Inhibitors of a Cancer Therapeutic Target, Nuclear Factor-κB (NF-κB)
  44. Role of viruses, prions and miRNA in neurodegenerative disorders and dementia
  45. Interleukin-10 Producing Regulatory B Cells Transformed CD4+CD25− Into Tregs and Enhanced Regulatory T Cells Function in Human Leprosy
  46. Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma
  47. Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options
  48. Recent Development and Future Prospects of Plant-Based Vaccines
  49. Clinical pharmacokinetic study for the effect of glimepiride matrix tablets developed by quality by design concept
  50. Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015)
  51. Updates on Traditional Medicinal Plants for Hepatocellular Carcinoma
  52. Nanomaterial Induced Immune Responses and Cytotoxicity
  53. Hepatic Cancer Stem Cells and Signaling Pathways
  54. Docking Studies of Pakistani HCV NS3 Helicase: A Possible Antiviral Drug Target
  55. Biomarkers for virus-induced hepatocellular carcinoma (HCC)
  56. Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches
  57. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma
  58. Potential mechanisms of hepatitis B virus induced liver injury